Sinus tissue resection devices market seen reaching $1.77 billion by 2030

The sinus tissue resection devices market is projected to grow from $1.29 billion in 2026 to $1.77 billion by 2030, according to The Business Research Company. Demand is being driven by chronic sinusitis cases, minimally invasive surgery adoption and expanded ENT care capacity, with North America leading and Asia-Pacific set to grow fastest.

Why it matters: - The market supports sinus surgery tools that help surgeons remove diseased tissue more precisely and reduce damage to healthy structures. - Rising demand matters because chronic sinusitis remains a major driver of physician visits and surgical intervention. - The market outlook points to continued investment in powered instruments, navigation systems and outpatient procedures.

What happened: - The Business Research Company released its Sinus Tissue Resection Devices Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 on August 26, 2026. - The report values the market at $1.19 billion in 2025 and $1.29 billion in 2026. - The report forecasts the market will reach $1.77 billion by 2030. - The report pegs the forecast period growth rate at 8.1% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - Sinus tissue resection devices are precision instruments used to remove diseased or obstructive tissue from sinus cavities. - These devices are designed to improve surgical control while limiting harm to surrounding healthy tissue. - The report says the market grew from $1.19 billion in 2025 to $1.29 billion in 2026, a historic CAGR of 8.4%. - The historical growth was driven by reliance on handheld instruments, slower early adoption of endoscopic methods, expansion of hospitals and specialty clinics, rising chronic sinusitis cases and conventional navigation and laser systems. - Future growth is expected to be fueled by powered microdebrider innovation, more integrated navigation and laser technologies, more outpatient and ambulatory sinus procedures, growth in ENT specialty clinics, stricter compliance and improved safety protocols. - The report highlights wider adoption of powered instruments, increased preference for endoscopic approaches, demand for minimally invasive solutions and expansion of ambulatory surgical centers. - Chronic sinusitis is described as inflammation lasting beyond 12 weeks and causing symptoms such as nasal congestion, facial pain and impaired smell. - The report links rising chronic sinusitis to exposure to allergens such as pollen and pollution. - A December 2023 report from TGH Urgent Care powered by Fast Track said nearly 29 million U.S. adults, or 11.6% of the adult population, had sinusitis in 2023. - Sinusitis remains one of the leading causes of physician visits.

Between the lines: - The forecast suggests the category is moving from traditional instruments toward more technology-enabled and minimally invasive systems. - Stronger growth in Asia-Pacific likely reflects broader healthcare investment and rising access to specialty ENT care. - The emphasis on outpatient procedures and ambulatory centers points to continued pressure to lower procedure complexity and recovery time.

What's next: - The report expects broader adoption of powered tools in sinus surgery. - The market is likely to keep shifting toward endoscopic and minimally invasive treatment models. - Expansion of ambulatory surgical centers and ENT specialty clinics should remain a key demand driver. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis.

The bottom line: - Sinus tissue resection devices are set for steady global growth as chronic sinusitis, minimally invasive surgery and outpatient care continue to expand.